Table 4.
Accuracy of different scoring systems in derivation and validation cohorts
| Models | Cut-off | Sensitivity (%) | Specificity (%) | Youden | AUROC (95%CI) | P value |
P
value
|
|
compared with GIMNS
| |||||||
| Derivation cohort (n = 248) | |||||||
| GIMNS | 0.4 | 73.5 | 78.7 | 0.522 | 0.830 (0.778-0.882) | < 0.001 | - |
| MELD | 24.8 | 61.4 | 76.6 | 0.380 | 0.759 (0.670-0.821) | < 0.001 | 0.029 |
| CLIF-SOFA | 9.0 | 72.7 | 68.1 | 0.408 | 0.767 (0.706-0.827) | < 0.001 | 0.045 |
| COSSH-ACLF | 7.5 | 56.8 | 84.0 | 0.408 | 0.759 (0.696-0.821) | < 0.001 | 0.026 |
| Validation cohort (n = 123) | |||||||
| GIMNS | 0.7 | 57.8 | 79.6 | 0.374 | 0.732 (0.642-0.821) | < 0.001 | - |
| MELD | 26.6 | 65.6 | 63.0 | 0.286 | 0.623 (0.520-0.726) | < 0.050 | 0.013 |
| CLIF-SOFA | 11.0 | 29.7 | 94.4 | 0.241 | 0.661 (0.563-0.758) | < 0.010 | 0.049 |
| COSSH-ACLF | 7.9 | 51.6 | 81.5 | 0.331 | 0.674 (0.577-0.770) | < 0.001 | 0.122 |
AUROC: Area under the receiver operating characteristic curve; CLIF-SOFA: Chronic liver failure-sequential organ failure assessment; COSSH-ACLF: Chinese Group on the study of severe hepatitis B-acute-on-chronic liver failure; MELD: Model for end-stage liver disease; CI: Confidence interval.